Probing the selectivity of allosteric modulators of muscarinic receptors at other G-protein-coupled receptors

被引:5
|
作者
Pfaffendorf, M
Batink, HD
Tränkle, C
Mohr, K
van Zwieten, PA
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Pharmacotherapy, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Bonn, Dept Pharmacol & Toxicol, D-53121 Bonn, Germany
来源
JOURNAL OF AUTONOMIC PHARMACOLOGY | 2000年 / 20卷 / 01期
关键词
D O I
10.1046/j.1365-2680.2000.00163.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
1 The aim of the present investigation was to analyse whether three prototype allosteric modulators of ligand binding to muscarinic receptors, i.e. alcuronium, gallamine, and the alkane-bis-ammonium compound W84 (hexane-1,6-bis[dimethyl-3'-phthalimidopropylammonium bromide]), may have allosteric effects on radioligand-binding characteristics at other G-protein-coupled receptors, such as cerebral A, adenosine receptors (G(i)-coupled), cardiac left ventricular alpha (1)-adrenoceptors (G(q)), and beta -adrenoceptors (G(s)). 2 The modulators were applied at concentrations known to be high with regard to the allosteric delay of the dissociation of the antagonist [H-3]-N-methylscopolamine (NMS) from muscarinic M-2-receptors: 30 mu mol l(-1) W84, 30 mu mol l(-1) alcuronium, 1000 mu mol l(-1) gallamine. As radioligands, we used the adenosine A(1)-receptor ligand [H-3]-cyclopentyl-dipropylxanthine (CPX), the alpha (1)-adrenoceptor ligand [H-3]-prazosin (PRAZ), and the beta -adrenoceptor ligand (-)-[I-125]-iodocyanopindolol (ICYP). Allosteric actions on ligand dissociation and the equilibrium binding were measured in the membrane fractions of rat whole forebrain (CPX) and of rat cardiac left ventricle (PRAZ, ICYP, NMS), respectively. 3 CPX and PRAZ showed a monophasic dissociation with half-lives of 5.88 +/- 0.15 and 12.27 +/- 0.46 min, respectively. In the case of CPX, neither the binding at equilibrium nor the dissociation characteristics were influenced by the allosteric agents. With PRAZ, the binding at equilibrium remained almost unaltered in the presence of W84, whereas it was reduced to 36 +/- 2% of the control value with alcuronium and to 42 +/- 2% with gallamine. The dissociation of PRAZ was not affected by W84, whereas it was moderately accelerated by alcuronium and gallamine. In the case of ICYP, the binding at equilibrium was not affected by the allosteric modulators. The dissociation of ICYP was slow, and after 3 h, more than 50% of the radioligand was still bound, so that a reliable half-life could not be calculated. ICYP dissociation was not affected by W84. In the presence of alcuronium and gallamine, the dissociation curve of ICYP revealed an initial drop from the starting level, followed by the major phase of dissociation being parallel to the control curve. 4 In summary, the allosteric action of the applied agents is not a common feature of G-protein-coupled receptors and appears to be specific for muscarinic receptors.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 50 条
  • [41] G-PROTEIN-COUPLED ORPHAN RECEPTORS
    PARMENTIER, M
    LIBERT, F
    VASSART, G
    M S-MEDECINE SCIENCES, 1995, 11 (02): : 222 - 231
  • [42] THE FAMILY OF G-PROTEIN-COUPLED RECEPTORS
    STRADER, CD
    FONG, TM
    GRAZIANO, MP
    TOTA, MR
    FASEB JOURNAL, 1995, 9 (09): : 745 - 754
  • [43] G-protein-coupled receptors and cancer
    Robert T. Dorsam
    J. Silvio Gutkind
    Nature Reviews Cancer, 2007, 7 : 79 - 94
  • [44] G-protein-coupled receptors on eosinophils
    Giembycz, MA
    Lynch, OT
    De Souza, PM
    Lindsay, MA
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2000, 13 (05) : 195 - 223
  • [45] Positive allosteric modulators for γ-aminobutyric AcidB receptors open new routes for the development of drugs targeting family 3 G-protein-coupled receptors
    Pin, JP
    Parmentier, ML
    Prézeau, L
    MOLECULAR PHARMACOLOGY, 2001, 60 (05) : 881 - 884
  • [46] G-protein-coupled receptors and their regulation - Activation of the MAP kinase signaling pathway by G-protein-coupled receptors
    Luttrell, LM
    vanBiesen, T
    Hawes, BE
    Koch, WJ
    Krueger, KM
    Touhara, K
    Lefkowitz, RJ
    SIGNAL TRANSDUCTION IN HEALTH AND DISEASE, 1997, 31 : 263 - 277
  • [47] Ligand Docking Methods to Recognize Allosteric Inhibitors for G-Protein-Coupled Receptors
    Harini, K.
    Jayashree, S.
    Tiwari, Vikas
    Vishwanath, Sneha
    Sowdhamini, Ramanathan
    BIOINFORMATICS AND BIOLOGY INSIGHTS, 2021, 15
  • [48] The pocketome of G-protein-coupled receptors reveals previously untargeted allosteric sites
    Hedderich, Janik B.
    Persechino, Margherita
    Becker, Katharina
    Heydenreich, Franziska M.
    Gutermuth, Torben
    Bouvier, Michel
    Buenemann, Moritz
    Kolb, Peter
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [49] G-protein-coupled receptors: From classical modes of modulation to allosteric mechanisms
    Bridges, Thomas M.
    Lindsley, Craig W.
    ACS CHEMICAL BIOLOGY, 2008, 3 (09) : 530 - 541
  • [50] The pocketome of G-protein-coupled receptors reveals previously untargeted allosteric sites
    Janik B. Hedderich
    Margherita Persechino
    Katharina Becker
    Franziska M. Heydenreich
    Torben Gutermuth
    Michel Bouvier
    Moritz Bünemann
    Peter Kolb
    Nature Communications, 13